- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05878873
The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis
The Neural Underpinnings and the Impact of Wearable Sensory Stimulation During Split-belt Treadmill Adaptation in People With Multiple Sclerosis
Majority of people with multiple sclerosis experience difficulty with balance and mobility, leading to an increased risk of falls. The goal of this clinical trial is to learn about brain activity during walking adaptation in people with multiple sclerosis. Also, this clinical trial will test a form of nerve stimulation to see if it can improve walking performance.
The main questions it aims to answer are:
- What areas of the brain are the most active during walking adaptation?
- Can nerve stimulation make walking adaptation more effective?
Participants will walk on a treadmill where each leg will go a different speed which will create walking adaptation. At the same time, brain scans will occur. There will be two sessions of walking adaptation, one with nerve stimulation, and one without nerve stimulation. Researchers will compare people with multiple sclerosis to healthy young adults to see if there are differences in brain activity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Fort Collins, Colorado, United States, 80523
- The Sensorimotor Neuroimaging Laboratory
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- A diagnosis of relapsing remitting multiple sclerosis OR a neurotypical adult (ages 18-86)
- Not experiencing an active relapse
- Able to stand and walk without an assistive device
- Able to walk for three tenths of a mile without stopping to rest
Exclusion Criteria:
- Unable to walk for three tenths of a mile without assistance
- Musculoskeletal injury in past 6 months
- Lower extremity surgery in past 6 months
- Unable to abstain from medications that impair balance
- Currently pregnant
- History of traumatic brain injury
- History of vestibular disease
- History of any other balance impairment unrelated to multiple sclerosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Split-belt Treadmill Training without TENS
During this arm, participants will perform split-belt treadmill training with sensory stimulation equipment outfitted but not active during all adaptation sessions.
|
Split-belt treadmill training, where the speed of each leg is controlled independently has been shown to create gait adaptation where the coordination of each leg is altered, creating improved gait symmetry for people with walking impairments.
|
|
Experimental: Split-belt Treadmill Training with TENS
During this arm, participants will perform split-belt treadmill training with active sensory stimulation occuring simultaneously during all adaptation sessions.
|
Split-belt treadmill training, where the speed of each leg is controlled independently has been shown to create gait adaptation where the coordination of each leg is altered, creating improved gait symmetry for people with walking impairments.
TENS is a form of nerve stimulation that stimulates at a frequency below motor threshold, targeting activation of sensory receptors, such as muscle spindles.
Electrodes that create this stimulation will be placed on the skin superficial to the muscle bellies of the tibialis anterior and rectus femoris.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Cortical Activation
Time Frame: Training session 1 (day 1), training session 2 (day 28)
|
Cortical activation is measured using functional near-infrared spectroscopy (fNIRS) during split-belt treadmill walking.
Hemodynamic responses are modeled using a general linear model (GLM) applied to the oxyhemoglobin (HbO) signal.
The model includes regressors for distinct phases of walking, with the primary contrast comparing early adaptation (strides 6-30 after split-belt onset) to a baseline walking period.
The outcome is defined as the difference in this HbO beta weight contrast with TENS ON compared to TENS OFF.
Activation is averaged across all fNIRS channels to provide a whole-brain estimate of cortical activity.
A larger value indicates a greater increase in activation from baseline walking to early adaptation.
This was measured on both training session 1 and training session 2 to account for the crossover design (i.e.
participants are receiving TENS on different days).
|
Training session 1 (day 1), training session 2 (day 28)
|
|
Change in Adaptation Savings
Time Frame: Training session 1 (day 1), training session 2 (day 28)
|
Adaptation savings is defined as the difference in early adaptation performance between training session 1 (Day 1) and training session 2 (Day 28) during split-belt treadmill walking. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length_fast - Step Length_slow) / (Step Length_fast + Step Length_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in SLA between visits (training session 2 - training session 1). Larger values reflect faster adaptation at training session 2, consistent with retention of prior learning. |
Training session 1 (day 1), training session 2 (day 28)
|
|
Rate of Step Length Asymmetry Adaptation
Time Frame: Training session 1 (day 1)
|
Step length asymmetry during early adaptation, representing the rate of adaptation. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length_fast - Step Length_slow) / (Step Length_fast + Step Length_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in early adaptation SLA during TENS ON compared to TENS OFF. Values closer to zero reflect faster adaptation.This analysis was performed only on data from each participant's first visit to avoid known effects of increased adaptation rate (learning) during subsequent exposures. |
Training session 1 (day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Phase Coordination Index
Time Frame: Baseline session 1 (day 1), post-training session 1 (day 1), baseline session 2 (day 14), and post-training session 2 (day 14)
|
The accuracy and consistency of step time compared to stride time, measured using three-dimensional motion capture and force plates.
|
Baseline session 1 (day 1), post-training session 1 (day 1), baseline session 2 (day 14), and post-training session 2 (day 14)
|
|
Change in Double Support Percent
Time Frame: Baseline session 1 (day 1), post-training session 1 (day 1), baseline session 2 (day 14), and post-training session 2 (day 14)
|
The percentage of time spent with both feet on the ground during walking, measured using three-dimensional motion capture and force plates.
|
Baseline session 1 (day 1), post-training session 1 (day 1), baseline session 2 (day 14), and post-training session 2 (day 14)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brett W Fling, Ph.D., Colorado State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1664
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Split-belt Treadmill
-
Hugo W. Moser Research Institute at Kennedy Krieger...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Hugo W. Moser Research Institute at Kennedy Krieger...University of Maryland; National Institutes of Health (NIH); National Institute... and other collaboratorsCompleted
-
University of FloridaWithdrawn
-
University of CalgaryRecruitingStroke | Stroke Gait Rehabilitation | Subacute Stroke | Stroke (Subacute)Canada
-
University of TorontoActive, not recruitingParkinson Disease | Freezing of Gait | Gait, UnsteadyCanada
-
The University of Texas Medical Branch, GalvestonCompleted
-
KU LeuvenUniversity of KielCompletedParkinson Disease | Freezing of GaitGermany, Belgium
-
Cairo UniversityCompletedCerebral PalsySaudi Arabia
-
Emory UniversityNational Institute on Aging (NIA)RecruitingLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers DiseaseMild Cognitive Impairment | Alzheimers DiseaseUnited States
-
KU LeuvenCompletedParkinson Disease | Freezing of Gait | Split-belt TreadmillBelgium